Fullstack Software Engineer, Aqemia
3+ days a week in office
AI and quantum physics driven drug discovery
Be an early applicant
AI and quantum physics driven drug discovery
21-100 employees
Be an early applicant
3+ days a week in office
21-100 employees
Company mission
To design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology.
Role
Who you are
- 4+ years of experience in fullstack software development
- Strong skills in Python (FastAPI or equivalent), SQL, and modern JavaScript frameworks (Vue.js or React)
- Experience with API design, frontend/backend integration, and user-centric design
- Good understanding of software architecture, security, testing, and deployment workflows
- Strong collaboration and communication skills, able to interact with non-technical users and turn their needs into working productsTeam player with the ability to work autonomously while staying aligned with team objectives
Desirable
- You want to build tools that make a real-world impact on drug discovery
- You combine clean, maintainable code and solid engineering practices (testing, documentation, performance) with a genuine curiosity for solving complex scientific problems
- You enjoy working in cross-functional teams and contributing beyond your code
What the job involves
- As a Fullstack Software Engineer, you will play a central role in building user-facing products supporting drug hunters daily activities and accelerating Aqemia’s drug discovery programs
- You’ll work closely with chemoinformaticians, AI scientists, and product stakeholders to create reliable, scalable applications that bring complex data and algorithms into the hands of scientists and decision-makers
- This role sits at the core of Aqemia’s product engineering effort, blending technical excellence, cross-functional collaboration, and a product mindset
- Design, develop, and maintain fullstack web applications powering Portfolio activities
- Implement intuitive user interfaces for internal scientific users (Vue.js or React)
- Build and maintain backend services in Python (FastAPI) with strong attention to performance and securityWork on the underlying PostgreSQL database, ensuring data integrity and optimized query performancCollaborate with chemoinformaticians and scientists to turn business needs into product features
- Ensure software quality, scalability, and testability through best practices (CI/CD, code reviews, testing)
- Contribute to improving our engineering culture, tools, and internal frameworks
- Participate actively in agile rituals and iterative product delivery
- Modern Stack & Challenges : Python, FastAPI, Airflow, Snowflake, Kubernetes, ML workflows, scientific infra, data engineering at scale
Our take
The billion dollar drug discovery industry is set to see notable growth by 2032 with huge R&D investments being made. It’s generally accepted that this is one of the most important financed sectors in the world. AQEMIA joined the discovery train in 2019 with its deep physics and AI enabled drug revelation pipeline.
The company boasts its intricate level of accuracy within its physics algorithms that are fed into AI discovery, leading to a level of speed and in turn scaling drug discovery at an impressive rate. Creating a name for itself AQEMIA moves away from using experimental data and bases the AI powered outcomes on years of data and studies of its now impressive team of 50.
Aqemia’s discoveries have already made an impact in oncology and immuno-oncology trials. The company sets goals to be part of more life changing clinical trials with wholly or partly owned drug candidates and with significant funding continues to scale its platform to continue wins in its research. It will be exciting to see how more research and collaborations like that with Servier (international pharmaceutical company) will continue to grow its success.
Steph
Company Specialist at Welcome to the Jungle
Company
Funding (last 2 of 6 rounds)
Apr 2025
$7.4m
GRANT
Dec 2024
$42.5m
EARLY VC
Total funding: $132.8m
Company HQ
Necker, Paris, France
Leadership
Maximilien Levesque
(Co-Founder & CEO)Currently a Board Member of France Biotech. Founded Personal HPC and worked through several roles at École normale supérieure most recently as a Research Group Leader.
Emmanuelle Martiano Rolland
(Co-Founder & COO)Previous Principal at Boston Consulting Group after completing a Master of Science Imperial College of London.
Share this job
View 4 more jobs at Aqemia